BioCryst to Present at Upcoming Investor Conferences

Rhea-AI Summary

BioCryst (NASDAQ:BCRX) will present at two investor conferences in May and June 2026. The company is scheduled to speak at the Bank of America Health Care Conference in Las Vegas on May 12, 2026 at 4:40 p.m. ET and at the Jefferies Global Healthcare Conference in New York on June 3, 2026 at 3:45 p.m. ET.

Live audio webcasts and replays will be available in the Investors & Media section of BioCryst’s website.

News Market Reaction – BCRX

-0.45%

5 alerts

-0.45% Session close to close

$2.25B Market Cap

8.55K Volume

In the Apr 28 session, BCRX declined 0.45%, reflecting a mild negative market reaction. Our momentum scanner triggered 5 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

RESEARCH TRIANGLE PARK, N.C., April 28, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the following conferences:

• Bank of America Health Care Conference in Las Vegas on Tuesday, May 12, 2026, at 4:40 p.m. ET.
• Jefferies Global Healthcare Conference in New York on Wednesday, June 3, 2026, at 3:45 p.m. ET.

Links to the live audio webcasts and replays of the presentations may be accessed in the Investors & Media section of BioCryst’s website at www.biocryst.com.

About BioCryst Pharmaceuticals

BioCryst is a global biotechnology company focused on developing and commercializing medicines for hereditary angioedema (“HAE”) and other rare diseases, driven by its deep commitment to improving the lives of people living with these conditions. BioCryst has commercialized ORLADEYO® (berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of potential first-in-class or best-in-class oral small-molecule and injectable protein therapeutics for a range of rare diseases. For more information, please visit www.biocryst.com or follow us on LinkedIn.

BCRXW

Contact:

Investors:
investorrelations@biocryst.com

Media:
media@biocryst.com

FAQ

When will BioCryst (BCRX) present at the Bank of America Health Care Conference?

BioCryst will present on May 12, 2026 at 4:40 p.m. ET. According to BioCryst, the presentation in Las Vegas will be available via live audio webcast and a replay in the Investors & Media section of the company website.

What is the BioCryst (BCRX) presentation time at the Jefferies Global Healthcare Conference?

BioCryst is scheduled to present on June 3, 2026 at 3:45 p.m. ET. According to BioCryst, investors can access a live audio webcast and later replay through the company’s Investors & Media website page.

How can investors access BioCryst (BCRX) live webcasts and replays for the May and June 2026 presentations?

Live audio webcasts and replays will be posted on BioCryst’s website Investors & Media section. According to BioCryst, links to both the May 12 and June 3 presentations will be available at www.biocryst.com for streaming and replay.

Will BioCryst (BCRX) provide replays of its investor conference presentations?

Yes, BioCryst will provide replays of the presentations on its website. According to BioCryst, live audio webcasts and subsequent replays for the May 12 and June 3 events will be accessible in the Investors & Media section.

Which investor conferences will BioCryst (BCRX) attend in May and June 2026?

BioCryst will attend the Bank of America Health Care Conference and the Jefferies Global Healthcare Conference. According to BioCryst, the company will present May 12, 2026 in Las Vegas and June 3, 2026 in New York, with webcasts available online.